A real-world study of MMB efficacy and its effects on immune cell populations in RUX-exposed as well as RUX-naive patients
Latest Information Update: 14 Feb 2025
At a glance
- Drugs Momelotinib (Primary) ; Ruxolitinib (Primary)
- Indications Myelofibrosis
- Focus Pharmacodynamics; Therapeutic Use
Most Recent Events
- 14 Feb 2025 New trial record